Cargando…
Therapies in ankylosing spondylitis—from clinical trials to clinical practice
Until recently, the therapeutic options for patients suffering from active AS comprised NSAIDs and TNF inhibitor therapy. Although these are effective in a significant proportion of patients, not all patients respond and some are intolerant to these therapies. Therefore, there is a clear unmet treat...
Autor principal: | Tahir, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238222/ https://www.ncbi.nlm.nih.gov/pubmed/30445480 http://dx.doi.org/10.1093/rheumatology/key152 |
Ejemplares similares
-
Ankylosing spondylitis functional and activity indices in clinical practice
por: Popescu, C, et al.
Publicado: (2014) -
Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021) -
Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives
por: Tahir, Hasan, et al.
Publicado: (2020) -
Teriparatide and vertebral fracture healing in Ankylosing Spondylitis
por: Biro, Izolda, et al.
Publicado: (2017) -
Ankylosing Spondylitis: A rheumatology clinic experience
por: Ahsan, Tasnim, et al.
Publicado: (2016)